|
⚲
|
| ACT Biotech Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001434913 |
| Sale | 2009-09-30 ($0.5 M Offered, $0.5 M Sold) |
| Fund | |
| Phone | 4152303901 |
| Address | 717 Market Street, Suite 650 San Francisco, 94103 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| John Mahoney | |
| Gary Lazar | |
| Ali Fattaey | |
| Wolfdieter Busse | |
| Nils Behnke | |
| Georg Nebgen | |
| John Costantino |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
TEEM Paul Lloyd Jr
✚
|
0.0 | |
|
Telesis-UL 2012 Q4 Project
✚
|
0.0 | |
|
Ivory 214 Funding, LLC
✚
|
0.0 | |
|
SVP Dislocation LLC
✚
|
0.0 | |
|
SVP Special Situations III LLC
✚
|
0.0 | |
|
Telfair Investment Fund, L.P.
✚
|
0.0 | |
|
Cross Peak Multi-Strategy Fund LP
✚
|
0.0 | |
|
Major Chord Partners, LLC
✚
|
0.0 | |
|
PureStake Inc.
✚
|
0.0 | |
|
Taylor Julian D.
✚
|
0.0 |